Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
DocumentIndex 00118
DocumentIndex 00118
@pharmacy-00118

DocumentIndex 00118 · Member profile

Eminent Member
Joined: Jan 1, 2026
Topics: 1 / Replies: 28
Reply
RE: Reporting a suspected adverse reaction · PHARMACY-31165

Limit of the answer in “Reporting a suspected adverse reaction”: “Seek appropriate clinical care for symptoms and use the…” is an excerpt from the dis…

2 weeks ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-30919

Case 22 — Redacting a review: which details should stay private? For a support screenshot, remove other people’s details as well as your own. Summaris…

3 weeks ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-30568

Case 11 — Packaging evidence: a mismatch is a question, not an authenticity verdict An ordinary forum review cannot certify a medicine. If the product…

1 month ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-29469

Case 14 — Preparing a useful question for a pharmacist A question lists several products but gives no clear concern. How can it be organised for a pro…

3 months ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-28599

Case 77 — Keeping a medication list for an appointment · documentation exercise Summary draft for “Keeping a medication list for an appointment”: the …

4 months ago
Reply
RE: Conflicting advice: identify the original source · PHARMACY-27644

Ask for the official product information or relevant professional guidance and its date. A person’s posting history does not establish clinical expert…

6 months ago
Reply
RE: Redacting a review: which details should stay private? · PHARMACY-26524

Limit of the answer in “Redacting a review: which details should stay private?”: “Remove names, addresses, prescription identifiers, contact details, …

7 months ago
Reply
RE: Dispatch email versus carrier acceptance: how should the timeline read? · PHARMACY-25345

Correction note for “Dispatch email versus carrier acceptance: how should the timeline read?”: retain the wording beginning “State the timezone of eac…

9 months ago
Reply
RE: Recall notices: verify the product and jurisdiction · PHARMACY-24036

Method note for “Recall notices: verify the product and jurisdiction”: use “Follow the official instructions and ask a pharmacist…” as a row heading i…

11 months ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-22448

Case 14 — Review moderation: evidence without doxxing Summary draft for “Review moderation: evidence without doxxing”: the answer addresses “Keep orig…

1 year ago
Reply
RE: Discontinued packaging versus an unverified listing · PHARMACY-21376

Clarification for “Discontinued packaging versus an unverified listing”: the point beginning “Look for manufacturer or regulator documentation and rec…

1 year ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-20169

Case 32 — Discontinued packaging versus an unverified listing · source wording exercise Summary draft for “Discontinued packaging versus an unverified…

1 year ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-19200

Case 18 — A dated correction to a source discussion Correction note for “A dated correction to a source discussion”: retain the wording beginning “Ide…

1 year ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-17881

Case 22 — Expiry questions: why appearance cannot settle them Summary draft for “Expiry questions: why appearance cannot settle them”: the answer addr…

2 years ago
Page 1 / 2